Arlevert

Medicinal product

(Invented) name

Arlevert

Active substance (s)

Cinarizinas/Dimenhidrinatas

Strength

20 mg/40 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07CA52, Cinnarizine, combinations

Marketing authorisation holder

Hennig Arzneimittel GmbH & Co. KG, Vokietija

Date of authorisation

2013-06-07

Date of renewal

2017-04-24

Documents

3314 Arlevert tab PL 2022 03 29_VRA 5486.docx

3314 Pakuotės lapelis 2022 03 29.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

AT/H/0500/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Cinarizinas	20 mg
Dimenhidrinatas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
49290	63159	1063159	lizdinė plokštelė	N20		Receptinis	LT/1/13/3314/001	Netiekiama	-	-	No	-	-
56314	70411	1070411	lizdinė plokštelė	N50		Receptinis	LT/1/13/3314/002	Tiekiama	-	-	No	-	-	Download
56315	70412	1070412	lizdinė plokštelė	N100		Receptinis	LT/1/13/3314/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-04-24	Perregistruotas
2013-06-07	Registruotas